The Infection Control Market is experiencing transformative growth driven by the urgent need to address the global antimicrobial resistance crisis and the persistent threat of emerging infectious diseases. Healthcare-associated infections caused by multidrug-resistant organisms such as MRSA, CRE, and Candida auris are creating substantial clinical and economic burdens that demand more...